- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Myriad Genetics Inc.
Headquarters: Salt Lake City, UT, United States of America
Website: http://www.myriad.com
Year Founded: 1991
Status: Public
Industry Sector: HealthTechnology
CEO: Paul J. Diaz
Number Of Employees: 2,700
Enterprise Value: $1,271,426,000
PE Ratio: -6.91
Exchange/Ticker 1: NASDAQ:MYGN
Exchange/Ticker 2: N/A
Latest Market Cap: $885,698,304
BioCentury | Aug 2, 2024
Management Tracks
James Wilson, gene therapy trailblazer, exits Penn to launch two newcos
Plus: Myriad hires Jennifer Fox as chief legal officer, and updates from Odyssey, Enveda and Accelerated Cure Project
BioCentury | Jan 31, 2024
Management Tracks
George Daneker to head clinical oncology at Myriad
Plus: TScan hires Jason Amello as CFO, and updates from CytoDyn, enGene and the Scleroderma Research Foundation
BioCentury | Dec 22, 2023
Management Tracks
Scott Leffler named CFO at Myriad
Plus: Brian MacDonald retires as chief innovation officer at Disc, and updates from BioAgeis and Sofinnova Partners
BioCentury | Dec 13, 2023
Data Byte
November follow-ons: Xenon raises more than one third of month’s total
Eight biopharmas brought in a combined $949M in follow-on financing; nearly all had gained value by the end of the month
BioCentury | Nov 2, 2023
Management Tracks
Sam Raha named COO at Myriad
Plus: Endeavor hires a new CMO, and updates from Jasper, Syantra, Ocuphire, Senisca and more
BioCentury | Oct 13, 2023
Management Tracks
CSO Lawson succeeding CEO Öhrström at VarmX
Plus: New CMO at Glycomine and updates from Halo, Roth, Sound Bioventures and the Global Virus Network
BioCentury | Dec 20, 2022
Management Tracks
MorphoSys’ CFO Lee leaving
Plus: Mestag names Logtenberg as chair and updates from Edgewise, Myriad and Venatorx
BioCentury | Jul 14, 2022
Finance
July 13 Quick Takes: Pliant raises $200M on back of positive data; CytomX restructuring
Plus ContraFect tumbles on exebacase setback, and updates from AgomAb, Xilis, and more
BioCentury | Mar 28, 2022
Management Tracks
Asif Ali to join Protagonist as CFO
Plus new CMO at Avenge Bio, new CEO at
BioCentury | Jan 5, 2022
Management Tracks
Maraganore joins n-Lorem as advisory council chair
Plus: Myriad CSO Lanchbury retiring and updates from Alnylam, Exelixis,
Items per page:
1 - 10 of 606